ReviewKorean journal of radiology
Imaging Evaluation Following
Review in Korean journal of radiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.
- Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy.Korean journal of radiology · 2019Pooled it
- LI-RADS TRA V2024: innovations in imaging assessment of hepatocellular carcinoma response to locoregional therapies.Abdominal radiology (New York) · 2026Review
- Temporal evolution of the LI-RADS radiation treatment response assessment on multiphase CT/MRI in patients undergoing selective internal radiation therapy for hepatocellular carcinoma.European radiology · 2025Article
- Article
- Radioembolization: Technical Tips and Follow-Up Imaging.Journal of the Korean Society of Radiology · 2025Review
- New frontiers in radioembolization.Therapeutic advances in medical oncology · 2024Review
- The Role of Radiomics and AI Technologies in the Segmentation, Detection, and Management of Hepatocellular Carcinoma.Cancers · 2022Review
- PET/CT withBiomedicines · 2022Article
- Radioembolization for hepatocellular carcinoma: what clinicians need to know.Journal of liver cancer · 2022Review
- Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma.Abdominal radiology (New York) · 2021Review
- Consensus report from the 9European radiology · 2021Review
- Artificial intelligence in assessment of hepatocellular carcinoma treatment response.Abdominal radiology (New York) · 2021Review
- Evaluation of qualitative and quantitative data of Y-90 imaging in SPECT/CT and PET/CT phantom studies.PloS one · 2021Article
- Characteristics of Recent Articles Published in the Korean Journal of Radiology Based on the Citation Frequency.Korean journal of radiology · 2020Article
- Selecting the Right Tool for the Right Job: Which Response Criteria Better Predicts Survival of Patients Treated with Transarterial Radioembolization?Gut and liver · 2020Article
- Assessment of Hepatocellular Carcinoma Response toRadiology. Imaging cancer · 2020Article
- Evaluation of liver tumour response by imaging.JHEP reports : innovation in hepatology · 2020Review
- Quantitative Imaging Biomarkers forJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019Article
- Combination of 1In vivo (Athens, Greece)Article
- Lung Shunt Reduction for Yttrium-90 Radioembolization: ChemoembolizationIn vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radioembolization using beta-emitting yttrium-90 microspheres is being increasingly used for the treatment of primary and metastatic liver cancers. It is a form of intra-arterial brachytherapy which delivers intense radiation to liver tumors with little embolic effect; this mode of action results in unique post-treatment imaging findings. It is important to understand these imaging findings to avoid misinterpretation of tumor response and to determine further management of the disease. Herein, we discuss the current concepts for assessing tumor response, common post-treatment imaging features, and associated complications following radioembolization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.